Theralase Technologies Inc
XTSX:TLT

Watchlist Manager
Theralase Technologies Inc Logo
Theralase Technologies Inc
XTSX:TLT
Watchlist
Price: 0.245 CAD 25.64% Market Closed
Market Cap: 60.7m CAD

Wall Street
Price Targets

TLT Price Targets Summary
Theralase Technologies Inc

Wall Street analysts forecast TLT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLT is 0.714 CAD with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.

Lowest
Price Target
0.707 CAD
189% Upside
Average
Price Target
0.714 CAD
191% Upside
Highest
Price Target
0.735 CAD
200% Upside
Theralase Technologies Inc Competitors:
Price Targets
BBNX
Beta Bionics Inc
61% Upside
338220
Vuno Inc
6% Upside
2216
Broncus Holding Corp
35% Downside
300760
Shenzhen Mindray Bio-Medical Electronics Co Ltd
38% Upside
688575
Shenzhen YHLO Biotech Co Ltd
16% Upside
100120
Vieworks Co Ltd
45% Upside
PRN
Profound Medical Corp
33% Upside
CYRX
Cryoport Inc
28% Upside

Revenue
Forecast

Revenue Estimate
Theralase Technologies Inc

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

-5%
Past Growth
227%
Estimated Growth
Estimates Accuracy
1%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Theralase Technologies Inc

Operating Income forecast
is not available for
Theralase Technologies Inc

Net Income
Forecast

Net Income Estimate
Theralase Technologies Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-27%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TLT's stock price target?
Price Target
0.714 CAD

According to Wall Street analysts, the average 1-year price target for TLT is 0.714 CAD with a low forecast of 0.707 CAD and a high forecast of 0.735 CAD.

What is Theralase Technologies Inc's Revenue forecast?
Projected CAGR
227%

For the last 13 years the compound annual growth rate for Theralase Technologies Inc's revenue is -5%. The projected CAGR for the next 3 years is 227%.

Back to Top